India's Pharmaceutical Exports

Country Profile

Côte d'Ivoire

Côte d'Ivoire is an emerging destination for Indian pharmaceutical exports — $63.9M in FY 2025–26, with 4.1× growth over the past decade. Medicines accounts for 66% of shipments, with vaccines contributing $14.7M. The compound annual growth rate since FY2016 stands at 15.1%.

🇨🇮 $63.9M · 4.1× growth since FY2016 · 15.1% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$63.9M
Exports FY2025–26 DGCIS
4.1×
Growth FY2016→2026
15.1%
CAGR FY2016→2026
66%
Medicines Share
5
Product Categories Supplied
Côte d'Ivoire is an emerging destination for Indian pharmaceutical exports — $63.9M in FY 2025–26, with 4.1× growth over the past decade. Medicines accounts for 66% of shipments, with vaccines contributing $14.7M. The compound annual growth rate since FY2016 stands at 15.1%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $42.4M (66.5%) Vaccines $14.7M (23.0%) Medicine Ingredients $5.81M (9.1%) Surgical & Hospital Supplies $795K (1.2%) Traditional & Herbal $134K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Côte d'Ivoire in the RBI overseas direct investment dataset (2011–2026).